Frontiers in Neurology (Apr 2021)
Prolonged Intubation in Patients With Prior Cerebrovascular Disease and COVID-19
- Shibani S. Mukerji,
- Shibani S. Mukerji,
- Sudeshna Das,
- Sudeshna Das,
- Haitham Alabsi,
- Haitham Alabsi,
- Haitham Alabsi,
- Laura N. Brenner,
- Laura N. Brenner,
- Aayushee Jain,
- Aayushee Jain,
- Colin Magdamo,
- Sarah I. Collens,
- Elissa Ye,
- Kiana Keller,
- Christine L. Boutros,
- Michael J. Leone,
- Amy Newhouse,
- Amy Newhouse,
- Amy Newhouse,
- Brody Foy,
- Brody Foy,
- Matthew D. Li,
- Matthew D. Li,
- Min Lang,
- Melis N. Anahtar,
- Yu-Ping Shao,
- Wendong Ge,
- Haoqi Sun,
- Haoqi Sun,
- Haoqi Sun,
- Virginia A. Triant,
- Virginia A. Triant,
- Virginia A. Triant,
- Virginia A. Triant,
- Jayashree Kalpathy-Cramer,
- Jayashree Kalpathy-Cramer,
- John Higgins,
- John Higgins,
- Jonathan Rosand,
- Jonathan Rosand,
- Jonathan Rosand,
- Gregory K. Robbins,
- Gregory K. Robbins,
- M. Brandon Westover,
- M. Brandon Westover,
- M. Brandon Westover,
- M. Brandon Westover
Affiliations
- Shibani S. Mukerji
- Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- Shibani S. Mukerji
- Harvard Medical School, Boston, MA, United States
- Sudeshna Das
- Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- Sudeshna Das
- Harvard Medical School, Boston, MA, United States
- Haitham Alabsi
- Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- Haitham Alabsi
- Harvard Medical School, Boston, MA, United States
- Haitham Alabsi
- Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States
- Laura N. Brenner
- Harvard Medical School, Boston, MA, United States
- Laura N. Brenner
- Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, MA, United States
- Aayushee Jain
- Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- Aayushee Jain
- Clinical Data A.I. Center (CDAC), Massachusetts General Hospital, Boston, MA, United States
- Colin Magdamo
- Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- Sarah I. Collens
- Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- Elissa Ye
- Clinical Data A.I. Center (CDAC), Massachusetts General Hospital, Boston, MA, United States
- Kiana Keller
- Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- Christine L. Boutros
- Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- Michael J. Leone
- Clinical Data A.I. Center (CDAC), Massachusetts General Hospital, Boston, MA, United States
- Amy Newhouse
- Harvard Medical School, Boston, MA, United States
- Amy Newhouse
- Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United States
- Amy Newhouse
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States
- Brody Foy
- Department of Pathology, Massachusetts General Hospital, Boston, MA, United States
- Brody Foy
- Department of Systems Biology, Harvard Medical School, Boston, MA, United States
- Matthew D. Li
- 0Department of Radiology, Massachusetts General Hospital, Boston, MA, United States
- Matthew D. Li
- 1Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, United States
- Min Lang
- 0Department of Radiology, Massachusetts General Hospital, Boston, MA, United States
- Melis N. Anahtar
- Department of Pathology, Massachusetts General Hospital, Boston, MA, United States
- Yu-Ping Shao
- Clinical Data A.I. Center (CDAC), Massachusetts General Hospital, Boston, MA, United States
- Wendong Ge
- Clinical Data A.I. Center (CDAC), Massachusetts General Hospital, Boston, MA, United States
- Haoqi Sun
- Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- Haoqi Sun
- Harvard Medical School, Boston, MA, United States
- Haoqi Sun
- Clinical Data A.I. Center (CDAC), Massachusetts General Hospital, Boston, MA, United States
- Virginia A. Triant
- Harvard Medical School, Boston, MA, United States
- Virginia A. Triant
- Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA, United States
- Virginia A. Triant
- 2Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States
- Virginia A. Triant
- 3The Mongan Institute, Massachusetts General Hospital, Boston, MA, United States
- Jayashree Kalpathy-Cramer
- 0Department of Radiology, Massachusetts General Hospital, Boston, MA, United States
- Jayashree Kalpathy-Cramer
- 1Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, MA, United States
- John Higgins
- Department of Pathology, Massachusetts General Hospital, Boston, MA, United States
- John Higgins
- Department of Systems Biology, Harvard Medical School, Boston, MA, United States
- Jonathan Rosand
- Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- Jonathan Rosand
- Harvard Medical School, Boston, MA, United States
- Jonathan Rosand
- Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States
- Gregory K. Robbins
- Harvard Medical School, Boston, MA, United States
- Gregory K. Robbins
- 2Division of Infectious Diseases, Massachusetts General Hospital, Boston, MA, United States
- M. Brandon Westover
- Department of Neurology, Massachusetts General Hospital, Boston, MA, United States
- M. Brandon Westover
- Harvard Medical School, Boston, MA, United States
- M. Brandon Westover
- Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA, United States
- M. Brandon Westover
- Clinical Data A.I. Center (CDAC), Massachusetts General Hospital, Boston, MA, United States
- DOI
- https://doi.org/10.3389/fneur.2021.642912
- Journal volume & issue
-
Vol. 12
Abstract
Objectives: Patients with comorbidities are at increased risk for poor outcomes in COVID-19, yet data on patients with prior neurological disease remains limited. Our objective was to determine the odds of critical illness and duration of mechanical ventilation in patients with prior cerebrovascular disease and COVID-19.Methods: A observational study of 1,128 consecutive adult patients admitted to an academic center in Boston, Massachusetts, and diagnosed with laboratory-confirmed COVID-19. We tested the association between prior cerebrovascular disease and critical illness, defined as mechanical ventilation (MV) or death by day 28, using logistic regression with inverse probability weighting of the propensity score. Among intubated patients, we estimated the cumulative incidence of successful extubation without death over 45 days using competing risk analysis.Results: Of the 1,128 adults with COVID-19, 350 (36%) were critically ill by day 28. The median age of patients was 59 years (SD: 18 years) and 640 (57%) were men. As of June 2nd, 2020, 127 (11%) patients had died. A total of 177 patients (16%) had a prior cerebrovascular disease. Prior cerebrovascular disease was significantly associated with critical illness (OR = 1.54, 95% CI = 1.14–2.07), lower rate of successful extubation (cause-specific HR = 0.57, 95% CI = 0.33–0.98), and increased duration of intubation (restricted mean time difference = 4.02 days, 95% CI = 0.34–10.92) compared to patients without cerebrovascular disease.Interpretation: Prior cerebrovascular disease adversely affects COVID-19 outcomes in hospitalized patients. Further study is required to determine if this subpopulation requires closer monitoring for disease progression during COVID-19.
Keywords
- cerebrovascular disease
- COVID-19
- respiratory failure
- stroke
- history of neurological disease
- intubation